Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard C Herrmann

JACC. Cardiovascular interventions

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
JACC. Cardiovascular Interventions|October 24, 2009
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitalsHoward C Herrmann, Jiandong Lu, Bruce R Brodie, et al.
JACC. Cardiovascular Interventions|August 20, 2018
The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 RegistryRebecca T Hahn, Philippe Pibarot, Jonathon Leipsic, et al.
JACC. Cardiovascular Interventions|April 23, 2021
Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT TrialRim Halaby, Howard C Herrmann, Zachary M Gertz, et al.
JACC. Cardiovascular Interventions|June 4, 2018
Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i TrialSuzanne J Baron, Vinod H Thourani, Susheel Kodali, et al.
JACC. Cardiovascular Interventions|July 26, 2014
Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve)Rebecca T Hahn, Philippe Pibarot, John Webb, et al.
JACC. Cardiovascular Interventions|April 8, 2022
5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical BioprosthesesRebecca T Hahn, John Webb, Philippe Pibarot, et al.
JACC. Cardiovascular Interventions|December 3, 2014
Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registryWilliam F Fearon, Susheel Kodali, Darshan Doshi, et al.
JACC. Cardiovascular Interventions|February 22, 2025
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic StenosisTayyab Shah, Zhiyuan Zhang, Haashim Shah, et al.
JACC. Cardiovascular Interventions|September 24, 2025
1-Year Outcomes of Transfemoral Transcatheter Mitral Valve Replacement With the Eos System: The MISCEND StudyRaj Makkar, Moody M Makar, Sabah Skaf, et al.
JACC. Cardiovascular Interventions|February 23, 2010
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)Gilles Montalescot, Stephen G Ellis, Mark A de Belder, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
JACC. Cardiovascular Interventions|October 24, 2009
Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitalsHoward C Herrmann, Jiandong Lu, Bruce R Brodie, et al.
JACC. Cardiovascular Interventions|August 20, 2018
The Effect of Post-Dilatation on Outcomes in the PARTNER 2 SAPIEN 3 RegistryRebecca T Hahn, Philippe Pibarot, Jonathon Leipsic, et al.
JACC. Cardiovascular Interventions|April 23, 2021
Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT TrialRim Halaby, Howard C Herrmann, Zachary M Gertz, et al.
JACC. Cardiovascular Interventions|June 4, 2018
Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i TrialSuzanne J Baron, Vinod H Thourani, Susheel Kodali, et al.
JACC. Cardiovascular Interventions|July 26, 2014
Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve)Rebecca T Hahn, Philippe Pibarot, John Webb, et al.
JACC. Cardiovascular Interventions|April 8, 2022
5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical BioprosthesesRebecca T Hahn, John Webb, Philippe Pibarot, et al.
JACC. Cardiovascular Interventions|December 3, 2014
Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registryWilliam F Fearon, Susheel Kodali, Darshan Doshi, et al.
JACC. Cardiovascular Interventions|February 22, 2025
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic StenosisTayyab Shah, Zhiyuan Zhang, Haashim Shah, et al.
JACC. Cardiovascular Interventions|September 24, 2025
1-Year Outcomes of Transfemoral Transcatheter Mitral Valve Replacement With the Eos System: The MISCEND StudyRaj Makkar, Moody M Makar, Sabah Skaf, et al.
JACC. Cardiovascular Interventions|February 23, 2010
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)Gilles Montalescot, Stephen G Ellis, Mark A de Belder, et al.
Pageof 3